Introduction
Recent approaches aimed at decreasing and/or slowing down the potential for quinoline-based antimalarial drug resistance has included the design and synthesis of quinoline containing dual inhibitors or "double drugs" that would potentially inhibit the haemozoin formation and another target within Plasmodium falciperum. This approach is exemplified by chloroquinoline-based isatin derivatives (Chiyanzu et al., 2005) , chloroquinoline-based β-carbolines (Gupta, Srivastava, Singh, Puri, & Chauhan, 2008) , ferrocine-chloroquinoline analogs (Beagley et al., 2003) , or the quinoline-inhibitors of a neutral zinc amino peptidase (Flipo, Florent, Grellier, Sergheraert, & Deprez-Poulain, 2003) . Studies revealed that compounds with a xanthene-based structure have antibacterial (Hideu, 1981) , anti-inflammatory (Poupelin et al., 1978) , and antiviral (Lamberk, Martin, Merrett, Parkes, & Thomas, 1997) activities. Antimalarial properties of several xanthene dyes such as pyronine Y, rhodamine 123, rhodamine 6G, and rhodamine B (Figure 1 ) have also appeared (Basco & Bras, 1994; Divo, Geary, Jensen, & Ginsburg, 1985; Ginsburg, Divo, Geary, Boland, & Jensen, 1986; Izumo & Tanabe, 1986; Vennerstrom, Makler, Angerhofer, & Williams, 1995) . Multicomponent reactions (MCRs), leading to interesting heterocyclic scaffolds, are particularly useful for the construction of diverse chemical libraries of "drug-like" molecules. In the present study, the xanthene nuclei and chloroquinoline functionality have been incorporated in a single molecule with variation of substituents and their positions on the aromatic ring via MCR methodology.
PUBLIC INTEREST STATEMENT
In the present study, the synthesis of a library of novel chloroquinoline containing xanthenes i.e. xanthene-chloroquinoline conjugates, via hybridizing the xanthene sub-structure and the chloroquinoline sub-structure, which is a wellknown antimalarial pharmacophore has been described. A novel series of chloroquinolinexanthene hybrids were prepared by one-pot multicomponent cyclo-condensation reaction of 2,7-dihydroxynaphthalene, aromatic aldehydes, and cyclic 1,3-dicarbonyl compounds followed by condensation reaction with 4,7-dichloroquinoline.
Results and discussion
Herein, we report synthesis and characterization of new chloroquinone-xanthene derivatives by a twostep procedure involving synthesis of xanthene derivatives and their reaction with 4,7-dichloroquinoline. The exploratory library of xanthene sub-structure, i.e. 12-aryl-2-hydroxy-8,9,10,12-tetrahydrobenzo[a] xanthene-11-one (1), was initially synthesized by the previously reported procedure by the authors via three-component cyclo-condensation of aldehydes, 1,3-dicarbonyl compounds (dimedone or 1,3-cyclohexadione) and 2,7-dihydroxynaphthalene using pTSA as a catalyst in refluxing ethanol (Scheme 1) (Khurana, Nand, & Sneha, 2011) . We decided to attempt the synthesis of these xanthene derivatives in water and were successful to synthesize them in refluxing water using H 2 SO 4 (10 mol %) as catalyst which gave comparable results.
After the successful synthesis of xanthene substructure via MCR strategy, our next aim was to synthesize the oxo-linked chloroquinoline-xanthene derivatives i.e. 12-aryl-2-(7-chloroquinolin-4-yloxy)-8,9,10,12-tetrahydrobenzo[a]xanthen-11-one (2) by condensation reaction between xanthene sub-structure and 4,7-dichloroqunoline. Initially, these derivatives were synthesized via the literature procedure (Sharma et al., 2009 ) which suffers from poor yields, long reaction times, use of DMF as a solvent under reflux, and use of column chromatography to purify the products, which forced us to modify the reaction conditions. A number of reactions were carried out to achieve the optimum conditions for this transformation by using different solvents and bases. As our ongoing efforts towards the use of water as a solvent for the synthesis of heterocycles (Khurana, Chaudhary, Lumb, & Nand, 2012a , 2012b Khurana, Nand, & Saluja, 2010) when 12-(4-chlorophenyl)-2-hydroxy-9,9-dimethyl-8,9,10,12-tetrahydrobenzo[a]xanthen-11-one (1) (1.0 equiv), 4,7-dichloroquinoline (1.0 equiv), and KOH (1.5 equiv) in 10 mL water-DMF (2 mL DMF and 8 mL water) was refluxed at 100°C, the reaction was complete in 2 h and 89% of 12-(4-chlorophenyl)-2-(7-chloroquinolin-4-yloxy)-9,9-dimethyl-8,9,10,12-tetrahydrobenzo[a] xanthen-11-one (2a) was obtained, by just filtration and washing with water and cold ethanol thereby eliminating the need of column chromatography for purification of the products. Thereafter, the optimized reaction conditions were used for the synthesis of various xanthene-chloroquinoline conjugates. All the reactions were complete in 2-3 h and pure products were obtained (Scheme 2, 
IR spectral data of compound 2a
In the IR spectrum of compound 2a (Figure 2 ), the observed peak at 1,651 cm −1 is characteristic for carbonyl (C=O) stretching frequencies of α, β-unsaturated ketone. Similarly, the C=C stretching frequency associated with α, β-unsaturated ketone was observed at 1,598 cm . Furthermore, the IR spectrum of 1a showed a band near 3,600 cm −1 for O-H stretching which was absent in the IR spectrum of its chloroquinoline analog (2a), and contains a very strong band at 1,221 (aryl conjugated) and 1,374 cm −1 for C-O-C stretching frequencies.
2.2.

H NMR spectral data of compound 2a
In the 1 H NMR spectrum of compound 2a (Figure 3 ), all aromatic protons were resonating in the range of δ 6.29-8.27. The proton corresponding to the CH (methine) of xanthene ring appeared as a singlet at H NMR spectrum of 1a exhibited a broad singlet at δ 11.00 ppm corresponding to the exchangeable OH proton, which was absent in b, which confirms the oxo linkage between xanthene nucleus and chloroquinoline.
2.3.
13
C NMR spectral data of compound 2a 
Mass spectral data of compound 2a
ESI-MS of 2a ( Figure 6 ) displayed m/z at 566 (M + + H) i.e. molecular ion peak (M) with addition of hydrogen corresponds to its molecular formula C 34 H 25 Cl 2 NO 3 and peaks at m/z 568 and 670 corresponding M + 2 and M + 4 peaks due to the presence of the two atoms of isotope ( 17 Cl 37 ) and further the peak intensities were found in accordance with the presence of isotopic atoms.
Single crystal X-ray structural data of compound 2g
We further decided to explore the X-ray crystallographic study of some of these xanthene-chloroquinoline conjugates. ORTEP of compound 2g is given in Figure 7 (CCDC No. 940413). The single crystals suitable for X-ray diffraction were grown by vapor diffusion of hexane into chloroform solution of the compound 2-(7-chloroquinoloyl-4-oxy)-9,9-dimethyl-12-(3-nitrophenyl)-8,9,10,12-tetrahydrobenzo[a] xanthen-11-one, 2g) at room temperature. A total of 13,195 reflections were measured out of which 6,333 were unique and 2,047 were considered observed (I > 2σ ( 
General
All the chemicals used were purchased from Sigma-Aldrich and used as received. Silica gel 60 F 254 (Precoated aluminum plates) from Merck were used to monitor the reaction progress. Melting points were recorded on a Tropical Labequip apparatus and were uncorrected. IR (KBr) spectra were recorded on Perkin-Elmer FTIR-1710 instrument and the values are expressed as ν max cm −1
. NMR spectra were recorded on Bruker Avance Spectrospin 300 MHz and on Jeol JNM ECX-400P at 400 MHz using TMS as the internal standard. Mass spectra were recorded on JEOL-AccuTOF JMS-T100 mass spectrometer having a DART source and on KC-455-TOF mass spectrometer (Micromass, Manchester, UK). The Cl ( temperature and poured on crushed ice and neutralized by dil. HCl if needed. A solid separated out after a while, which was filtered, washed with water and cold ethanol, and dried under vacuum to obtain pure 2-(7-chloroquinolin-4-yloxy)-12-aryl-8,9,10,12-tetrahydrobenzo[a]xanthen-11-ones (2a-g). 75, 163.60, 161.19, 152.84, 152.38, 150.29, 148.50, 144.40, 136.19, 132.60, 131.06, 129.19, 128.72, 128.39, 128.31, 128.14, 127.21, 126.37, 132.42, 120.02, 119.13, 117.55, 117.04, 113.96, 113.88, 104.98, 50.80, 41.34, 34.87, 32.27, 29.20, 27.22 196.68, 163.74, 161.15, 153.07, 152.34, 150.36, 148.51, 143.43, 136.30, 132.44, 131.49, 131.17, 130.10, 129.20, 129.01, 128.20, 127.29, 123.38, 120.27, 119.24, 117.01, 113.64, 113.44, 105.05, 50.77, 41.33, 34.47, 32.25, 29.19, 27.21 196.79, 163.50, 161.21, 152.82, 152.31, 150.29, 148.43, 141.52, 136.20, 135.86, 132.61, 131.04, 129.20, 129.07, 128.60, 128.18, 128.13, 127.22, 123.45, 120.06, 119.08, 117.75, 117.06, 114.09, 113.91, 105.08, 50.83, 41.35, 34.48, 32.29, 29.21, 27.32, 21. 196.54, 164.40, 161.11, 153.48, 152.19, 151.39, 150.43, 148.65, 146.45, 136.39, 132.39, 131.34, 129.53, 129.23, 128.28, 127.39, 123.71, 123.33, 119.99, 119.37, 117.07, 115.91, 113.03, 112.84, 105.35, 50.70, 41.36, 34.49, 32.28, 29.23, 27.11 196.80, 163.66, 161.22, 159.61, 152.99, 152.28, 150.33, 148.52, 140.15, 136.28, 132.50, 131.15, 129.88, 129.78, 129.22, 128.91, 128.18, 127.28, 123.40, 120.01, 119.20, 117.21, 117.05, 115.33, 115.05, 113.82, 113.70, 105.05, 50.79, 41.32, 34.14, 32.27, 29.23, 27.15 196.65, 164.38, 161.21, 153.41, 152.19, 150.38, 148.74, 148.60, 146.36, 136.34, 134.84, 132.32, 131.41, 129.58, 129.29, 129.11, 128.25, 127.36, 123.36, 122.88, 121.69, 119.97, 119.36, 117.23, 115.76, 113.16, 112.94, 105.27, 50.71, 41.32, 34.78, 32.32, 29.14, 27.22; MS (ESI) = 4.8 Hz, 1H, Ar], 8.27 (d, J = 8.7 Hz, 1H, Ar), 8.11 (s, 1H, Ar), 7.92 (d, J = 8.7 Hz, 1H, Ar), 7.84 (d, J = 9.0 Hz, 1H, Ar), 7.62 (s, 1H, Ar), 7.53 (d, J = 8.7 Hz, 1H, Ar), 7.36 (d, J = 9.0 Hz, 1H, Ar), 4H, Ar) 196.59, 163.94, 161.19, 153.09, 152.38, 150.36, 148.60, 146.59, 136.24, 132.48, 131.21, 131.07, 129.86, 129.69, 129.24, 129.11, 128.21, 127.29, 127.26, 123.41, 122.61, 120.01, 119.29, 117.10, 116.61, 113.58, 113.43, 105.03, 50.78, 41.35, 34.61, 32.31, 29.17, 27.31; MS (ESI) 197.01, 163.46, 161.02, 153.01, 152.19, 150.08, 148.14, 135.96, 133.32, 132.94, 130.94, 130.49, 129.08, 128.47, 120.43, 127.99, 127.56, 127.23, 126.91, 126.14, 125.57, 125.32, 123.54, 123.27, 119.82, 119.39, 119.21, 117.18, 114.78, 114.13, 104.40, 50.70, 41.45, 32.18, 31.34, 29.22, 27.27 196.77, 163.67, 161.01, 152.79, 152.26, 150.23, 148.57, 141.77, 136.16, 133.23, 132.61, 132.12, 131.09, 129.23, 128.85, 128.20, 128.10, 128.02, 127.42, 127.15, 127.09, 126.48, 126.00, 125.73, 123.39, 119.97, 119.17, 11.41, 117.07, 113.93, 113.74, 104.72, 50.82, 41.39, 35.06, 32.26, 29.21, 27.28 ; MS (ESI) m/z = 582 (M + + H), 584 (M + 2).
12-(4-Chlorophenyl)-2-(7-chloroquinolin-4-yloxy)-
3.13. 12-(9-Anthryl)-2-(7-chloroquinolin-4-yloxy)-9,9-dimethyl-8, : δ 197.26, 163.32, 161.54, 152.68, 152.12, 149.94, 148.05, 135.86, 134.69, 133.43, 131.95, 131.01, 130.85, 130.80, 130.13, 129.87, 129.27, 129.16, 128.93, 128.41, 127.87, 126.73, 126.33, 125.05, 124.35, 124.09, 123.97, 123.49, 123.17, 119.61, 119.22, 118.56, 116.91, 115.72, 113.70, 103.77, 50.87, 41.48, 31.97, 30.99, 29.06, 27.49 196.89, 165.31, 161.16, 152.84, 152.39, 150.29, 150.53, 144.70, 136.18, 132.85, 131.06, 129.19, 128.73, 128.44, 128.40, 129.15, 127.20, 126.39, 123.42, 120.02, 119.13, 117.56, 116.98, 115.24, 113.89, 104.95, 36.96, 34.82, 27.68, 20.23 196.90, 165.19, 161.17, 152.82, 152.31, 150.32, 148.48, 141.82, 136.18, 135.91, 132.60, 131.02, 129.19, 129.11, 128.61, 128.26, 128.16, 127.20, 123.43, 120.06, 119.07, 117.75, 116.98, 115.40, 113.91, 105.04, 36.97, 34.41, 27.67, 21.01, 20.25 
